Article: Emergingstockreport.com initiates (complimentary) research coverage on: Hemispherx Biopharma (NYSE AMEX:HEB).

M2 PRESSWIRE-12 June 2009-Emerging Stock Report: Emergingstockreport.com initiates (complimentary) research coverage on: Hemispherx Biopharma (NYSE AMEX:HEB)(C)1994-2009 M2 COMMUNICATIONS

RDATE:12062009

+Emerging Stock Report is currently offering a complimentary trial subscription. To view our research go to www.emergingstockreport.com Emerging Stock Report a leading provider of small and micro cap independent investment research, today initiated coverage on: Hemispherx Biopharma (NYSE AMEX:HEB) , sector: Healthcare. industry: Pharmaceuticals - Diversified

June 12,2009 - Hemispherx Biopharma (NYSE AMEX:HEB) announced today that its ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!